To my readers…

images-2I have received a lot of email from readers who are asking why the change in my support of the pharmaceutical industry?  I want to take a moment to explain why I have started to really question whether the industry cares about customers or just profit. Continue reading »

On mobile and pharma

iphonesymnavKEY TAKEAWAY: Pharma companies are not prepared to develop, launch and support mobile apps because it requires additional investment at a time when pharma looks at the cost as opposed to the value. Continue reading »

The new dawn of DTC marketing: Innovation

When it comes to marketing, especially DTC marketing, I read everything I can get my hands on so I can better understand the challenges facing the industry. This much is certain; the drug industry is facing a huge challenge to keep DTC marketing relevant.  The challenge is not only in reaching consumers and providing them with the information they need to make a decision, it’s also innovation within the company so that new marketing initiatives can be implemented. Continue reading »

How mobile users are accessing health info

imagesKEY TAKEAWAY: While more people are using the Internet for health the majority of them are accessing health information on desktop/laptop PC’s not mobile devices. However, they will access drug.com sites if they are given an Rx for a drug to learn about the product before filling their prescription. Continue reading »

Prescription drug costs soaring

screenshot_27910 selected new medications are likely to result in medication costs to the government of $49.3 billion over a 10-year period, including: $31.3 billion in Medicare spend; $15.8 billion in state and federal Medicaid spend; and $2.1 billion as a result of subsidies provided through exchange plans. Continue reading »

Trust: The missing ingredient in DTC marketing

screenshot_277KEY TAKEAWAY: For most pharma products trust is an essential element of DTC marketing that seems to be largely ignored.  Breakthrough therapies will always find a market, but for the vast majority of other drugs pharma is going to have to earn the trust of a skeptical public. Continue reading »